Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Aug;171(2):493-502.
doi: 10.1016/0042-6822(89)90619-3.

Stably expressed FIPV peplomer protein induces cell fusion and elicits neutralizing antibodies in mice

Affiliations

Stably expressed FIPV peplomer protein induces cell fusion and elicits neutralizing antibodies in mice

R J De Groot et al. Virology. 1989 Aug.

Abstract

We have established bovine papilloma virus (BPV)-transformed mouse C127 cell lines that synthesize the peplomer protein of the feline infectious peritonitis virus (FIPV) strain 79-1146. For this purpose, a new cassette expression vector pHSL, which carries the Drosophila HSp70 promotor and the polyadenylation signal of the Moloney murine leukemia virus long terminal repeat, was constructed. Cocultivation of the BPV-transformed cell lines with FIPV-permissive feline fcwf-D cells resulted in polykaryocyte formation. Since it depended on the presence of fcwf-D cells, binding of E2 to the cell receptor may be required for membrane fusion. E2 was synthesized as a core-glycosylated protein of 180K which was only slowly transported from the endoplasmic reticulum to the medial Golgi: of the E2-molecules labeled during a 1-hr pulse about half was still completely sensitive to endoglycosidase H after a 2-hr chase, while the remaining E2 had been chased into multiple, partially endoglycosidase H-resistant forms. Immunofluorescence studies also indicated that most E2 was retained intracellularly. Mice immunized with whole lysates of the transformed cells produced FIPV-neutralizing antibodies as shown by plaque reduction.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Binns M.M., Boursnell M.E.G., Cavanagh D., Pappin D.J.C., Brown T.D.K. Cloning and sequencing of the gene encoding the spike protein of the coronavirus IBV. J. Gen. Virol. 1985;66:719–726. - PubMed
    1. Buchmeier M.J., Lewicki H.A., Talbot P.J., Knobler R.L. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology. 1984;132:261–270. - PMC - PubMed
    1. Cavanagh D. Coronavirus IBV: Structural characterization of the spike protein. J. Gen. Virol. 1983;64:2577–2583. - PubMed
    1. Cavanagh D., Davis P.J., Darbyshire J.H., Peters R.W. Coronavirus IBV: Virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or hemagglutinin-inhibiting antibody, or induce chicken tracheal protection. J. Gen. Virol. 1986;67:1435–1442. - PubMed
    1. Copeland C.S., Doms R.W., Bolzau E.M., Webster R.G., Helenius A. Assembly of influenza hemagglutinin trimers and its role in intracellular transport. J. Cell Biol. 1986;103:1179–1191. - PMC - PubMed

LinkOut - more resources